BioClonetics is a biotechnology company engaged in the discovery, acquisition and development of proprietary pharmaceutical compounds and new technologies for use in the diagnosis and treatment of HIV/AIDS and other infectious diseases. BioClonetics has created a human cell line that produces a human antibody (designated as CLONE 3) that neutralizes HIV, the virus that causes AIDS.
